|
| WESS03 |
Microbicides and PrEP: Back to Basics |
| |
Special Session
|
| Venue: |
Session Room 3 |
| Time: |
25.07.2012, 13:00 - 14:00 |
|
Chair:
|
Ian McGowan, United States
|
| |
| |
| The recent successes in Microbicides and PrEP trials define a turning point in biomedical prevention research. This session will reference the current state of microbicides and PrEP research and outline a path for future research and implementation. Following a series of brief presentations discussing the next steps in research needed to advance the field, a panel will provide real world considerations for making PrEP and microbicides available to the public. |
|
|
13:00
| Introduction
| 13:02
WESS0301
Webcast | Microbicides and PrEP: where we've been, where we are going
I. McGowan, United States
| 13:10
WESS0304
Powerpoint
Webcast | Microbicides and PrEP: what can be learned from animal models?
J. Garcia-Lerma, United States
| 13:18
WESS0302
Powerpoint
Webcast | The role of semen and genital tract inflammation on HIV acquisition in women
B. Herold, United States
| 13:26
WESS0303 | Drug levels and correlates of protection: drug formulation and implications for drug levels in the genital and anal compartments
A. Kashuba, United States
| 13:34
WESS0305
Webcast | Considerations for implementing microbicides and PrEP in the real world
N. Mugo, Kenya
| 13:42
| Questions and answers
| 13:57
| Conclusion
|
|
| Powerpoints presentations |
| Microbicides and PrEP: what can be learned from animal models? - J. Gerardo Garcia-Lerma | |
| The role of semen and genital tract inflammation on HIV acquisition in women - Betsy Herold | |
|
|